Rongfeng Fu

13PUBLICATIONS
40CO-AUTHORS
Economic models and forecastingAutoimmunityTissue engineeringInfant and child healthCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 18, 2026
External validation of the AAA+ survival model in a large Chinese cohort with essential thrombocythaemia.

|Apr 29, 2026
Low-dose oral nicotinamide mononucleotide for immune thrombocytopenia: a phase 1/2 trial.

|Mar 12, 2026
Phase 1 pilot study for hemophilia-A: AAV8 vector with prophylactic tacrolimus-glucocorticoid achieves therapeutic FVIII activity.

Wei Liu, Xiaolei Pei, Tenghui Yu

|Oct 07, 2024
Childhood and adolescent essential thrombocythemia and prefibrotic primary myelofibrosis: insights into diagnosis, outcomes, and treatment from a large Chinese cohort.

Rongfeng Fu, Huan Dong, Wenjing Gu

|Sep 27, 2024
Reduced Platelet Activation in Triple-Negative Essential Thrombocythemia Compared with JAK2V617F-Mutated Essential Thrombocythemia.

Huan Dong, Jia Chen, Jing Zhang

|Sep 10, 2024
Integrating chemokines and machine learning algorithms for diagnosis and bleeding assessment in primary immune thrombocytopenia: A prospective cohort study.

Qing Wen, Ting Sun, Jia Chen

Pageof 3

Frequent Collaborators

13 joint publications

Lei Zhang

9 joint publications

Yunfei Chen

7 joint publications

Feng Xue

6 joint publications

Huan Dong